期刊文献+

诱导型一氧化氮合酶抑制剂对地鼠颊囊癌变的干预作用 被引量:4

Intervention Effect of an Inducible Nitric Oxide Synthase Inhibitor on Carcinogenesis of Hamster Cheek Pouch Carcinoma
下载PDF
导出
摘要 目的 研究一氧化氮(NO)在肿瘤发生发展过程中所起的作用,探讨一氧化氮合酶(NOS)抑制剂对地鼠颊囊粘膜癌变所起的干预作用。方法 90只金黄地鼠分为实验1组(T1组)、实验2组(T2组)和空白对照组(C组),利用二甲基苯并蒽(DMBA)诱导T1、,12组地鼠颊囊癌变,并在T2组给予一氧化氮合酶抑制剂L硝基精氨酸甲酯(L-NAME),观察T1和12组颊囊黏膜癌变中病理改变,SABC免疫组化法检测iNOS、VECF、Ⅷ因子动态表达,硝酸还原酶法测定NO量的变化。结果 DMBA诱导T1组和T2组颊囊黏膜癌变率的差异有统计学意义,P<0.05,iNOS、VEGF阳性表达增加,NO量和微血管密度不断增加。结论 NO在地鼠颊囊癌的发生发展中起促进作用,而L-NAME起干预作用。 Objective To observe the expression changes of VEGF, iNOS and the level of MVD and NO during the evolution of Golden hamster cheek pouch carcinogenesis. To observe the pathological change during the evolution of Golden hamster cheek pouch carcinogenesis. To study the effect of NO in carcinogenesis in the pouch of hamster, and to investigate the effect of NOS in-hibiter L-NAME in interfering with carcinogenesis. Methods 90 golden hamsters were divided into three groups: 40 in experiment group, 40 in control group and 10 in blank group. DMBA was painted on hamster's cheek pouch in experiment and control group, L-NAME was given to hamster in experiment group at the dose of 0.02 ml/g. Hamsters were killed at 6,9,12 and 16 weeks, respectively. The blank group was killed at the 16 week. SABC immunohistochemistry assay was used to detect the expression of iNOS, VEGF and factorⅧ -related antigen. MVD was measured. The level of NO was measured by Spectrophotometry. Results The difference between control group and experiment group at the 12th week and 16th week was observed. The difference of positive expression rate of iNOS in all group was significant and difference between blank group and control group was significant, The difference of positive expression rate of VEGF in all group was significant and difference between blank group and control group at the 12 and 16 week was significant; there was significant difference in every group MVD from the 6 week control group to the 16th week control. There were significant difference among the control group, except the 6 week of experiment and control group. Conclusion There is an increased expression of iNOS and the level of NO, as well MVD during the evolution of Golden hamster cheek pouch carcinogenesis from slightly dysplasia to invasive carcinoma. NO plays an important role during the evolution of carcinogenesis, and iNOS inhibitor L-NAME can inhibit the carcinogenesis.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2004年第5期357-361,共5页 West China Journal of Stomatology
基金 广东省自然科学基金资助项目(31698)
关键词 一氧化氮合酶 抑制剂 血管内皮生长因子 微血管密度 nitric oxide synthase inhibitor carcinoma vascular endothelial growth factor microvascular density
  • 相关文献

参考文献12

  • 1Xie K, Huang S, Dong Z,et al. Destruction of bystander cells by tumor cells transfected with inducible nitric oxide synthase gene[J]. J Natl Cancer Inst,1997,89(6):421-427.
  • 2Weidner N. Current pathologic methods for measuring intratumoral microvessel density with breast carcinoma and other solid tumors[J]. Breast Cancer Res Treat,1995,36(2):169-180.
  • 3Beckman JS. The double-edged role of Nitric Oxide in brain function and superoxide-mediated injury[J]. J Dev Physiol,1991,15(1):53-59.
  • 4Kanner J, Harel S, Granit R, et al. Nitric oxide as an antioxidant[J].Arch Biochem Biophys,1991,289(1):130-136.
  • 5Rosbe KW, Prazma J,Petrusz P,et al. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck[J]. Otolaryngol Head Neck Surg,1995,5(13):541-549.
  • 6Zagzag D. Angiogenic growth factor in neural embryogenesis and neoplasia[J]. Am J Pathol,1995,146(2):293-297.
  • 7Ziche M, Morbidelli L, Choudhuri R, et al. Nitric oxide synthase lies downs steam from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis[J]. J Clin Invest,1997,99(11):2625-2634.
  • 8Morbidelli L, Chang CH, Douglas JG. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium[J]. Am J Physiol,1996,270(1Pt2):H411-415.
  • 9Rao CV, Indranie C, Simi B, et al. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib,a selective cyclooxygenase-2 inhibitor[J]. Cancer Res,2002,
  • 10Thomsen LL, Scott JM, Topley P, et al. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor[J]. Cancer Res,1997,57(1):3300-3304.

二级参考文献10

  • 1刘耕陶,中华医学杂志,1996年,76卷,563页
  • 2Gallo O, Masini E, Morbidelli L, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer [J]. J Natl Cancer Inst, 1998,90(8):587-596.
  • 3Rosbe J, Kristina W, Petrusz P, et al. Immunohistochemical characterzation of nitric oxide synthase activity in squamous cell carcinoma of the head and neck [J]. Otolaryngology Head & Neck Surgery, 1995,113(5):541-549.
  • 4Thomsen LL, James MJ, Scott, et al. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo:studies with 1400W, a novel inhibitor [J]. Cancer Res, 1997,57:3300-3304.
  • 5Chin K, Kurashima Y, Ogura T, et al. Induction of Vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular Carcinoma Cells [J]. Oncogene,1997,15:437-442.
  • 6Meyer RE, Shan S, DeAngelo J, et al. Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma [J]. Br J Cancer,1995,11:1169-1174.
  • 7Lejeune P, Lagadec P, Onier N, et al. Nitric oxide involvment in tumor-induced immunosuppression [J]. J Immunol, 1994,152:5077-5083.
  • 8Yagihashi N, Kasajima H, Sugai S, et al. Increased in situ expression of nitric oxide synthase in human coorectal cancer [J]. Virchows-Arch,2000,436(2):109-114.
  • 9Orucevic A,Bechberger J,Green AM,et al.Nitric-oxide production by murine mammary adenocarcinoma cell promotes tumor-cell invasiveness [J]. Int J Cancer, 1999,81:889-896.
  • 10陈伟良,李海刚,潘朝斌,黄洪章.一氧化氮合酶在舌鳞癌组织中的表达及其与预后的关系[J].中华口腔医学杂志,1998,33(3):152-154. 被引量:27

共引文献39

同被引文献45

  • 1曾曙光,周磊,陈伟良,艾伟健,宋光保,李海刚.舌鳞癌与其颈淋巴结转移癌组织中iNOS与COX-2的表达差异[J].中山大学学报(医学科学版),2006,27(2):157-160. 被引量:10
  • 2JACOBY R F,SEIBERT K,COLE,et al.The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis[J].Cancer Res,2000,60(18):5040-5044.
  • 3KONG G,KIM E K,KIM W S,et al.Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer[J].J Gastroenterol Hepatol,2002,17(8):914-921.
  • 4CIANCHI F,CORTESINI C,FANTAPPIE O,et al.Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in eoloreetal cancer[J].Clin Cancer Res,2004,10(8):2694-2704.
  • 5OZEL E,PESTERELI H E,SIMSEK T,et al.Expression of cyclooxygenase-2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas:is there any correlation with angiogenesis or clinicopathologic parameters?[J].Int J Gynecol Cancer,2006,16(2):549-555.
  • 6GALLO O,SCHIAVONE N,PAPUCCI L,et al.Down.-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma[J].Am J Pathol,2003,163(2):723-732.
  • 7YOSHIDA K,TANAKA T,KOHNO H,et al.A COX2 inhibitor,nimesulide,inhibits chemically-induced rat tongue carcinogenesis through suppression of cell roliferation activity and COX-2 and iNOS expression[J].Histol Histopathol,2003,18(1):39-48.
  • 8XIONG B,SUN T J,YUAN H Y,et al.Cyclooxygenase 2 expression and angiogenesis in colorectal cancer[J].World J Gastroenterol,2003,9(6):1237-1240.
  • 9OHNO R,YOSHINAGA K,FUJITA T,et al.Depth of invasion parallels increased cyelooxygenase-2 levels in patients with gastric carcinoma[J].Cancer,2001,91(10):1876-1881.
  • 10KOIDE N,SUGIYAMA T,MU M M,et al.Gamma interferon-induced nitric oxide production in mouse CD5+B1-like cell line and its association with apoptotic cell death[J].Microbiol Immunol,2003,47(9):669-679.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部